The Danish National Multiple Myeloma Registry

The Danish National Multiple Myeloma Registry

Peter Gimsing,1 Morten O Holmström,2 Tobias Wirenfelt Klausen,3 Niels Frost Andersen,4 Henrik Gregersen,5 Robert Schou Pedersen,6 Torben Plesner,7 Per Trøllund Pedersen,8 Mikael Frederiksen,9 Ulf Frølund,2 Carsten Helleberg,3 Annette Vangsted,1 Peter de Nully Brown,1 N...

Full description

Bibliographic Details
Main Authors:	Gimsing P, Holmström MO, Klausen TW, Andersen NF, Gregersen H, Pedersen RS, Plesner T, Pedersen PT, Frederiksen M, Frølund U, Helleberg C, Vangsted A, de Nully Brown P, Abildgaard N
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-10-01
Series:	Clinical Epidemiology
Subjects:	Multiple Myeloma Registry Population-based Treatment Response Progression free survival Overall Survival
Online Access:	https://www.dovepress.com/the-danish-national-multiple-myeloma-registry-peer-reviewed-article-CLEP

Similar Items

Connect MM Registry as a national reference for United States multiple myeloma patients
by: Sikander Ailawadhi, et al.
Published: (2020-01-01)

Time trends in survival and causes of death in multiple myeloma: a population-based study from Germany
by: Christine Eisfeld, et al.
Published: (2023-04-01)

The Danish National Chronic Lymphocytic Leukemia Registry
by: da Cunha-Bang C, et al.
Published: (2016-10-01)

EPIDEMIOLOGY OF MULTIPLE MYELOMA ACCORDING TO THE КIROV REGION POPULATION REGISTERS
by: A. S. Luchinin, et al.
Published: (2017-10-01)

Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination
by: Zhenhai Li, et al.
Published: (2020-08-01)

The diagnostic and prognostic values of circulating miRNA-1246 in multiple myeloma
by: Guimin Zhao, et al.
Published: (2022-12-01)

Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study
by: Jian Hou, et al.
Published: (2017-07-01)

What are the factors affecting survival after autologous stem cell transplantation in patients with multiple myeloma?
by: Serife Solmaz, et al.
Published: (2020-01-01)

Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
by: Bei Wang, et al.
Published: (2022-10-01)

Comprehensive analysis of prognosis of cuproptosis-related oxidative stress genes in multiple myeloma
by: Tingting Li, et al.
Published: (2023-03-01)

A prognostic model for patients with primary extramedullary multiple myeloma
by: Limei Zhang, et al.
Published: (2022-11-01)

The Effects of Second Primary Malignancies and Frailty on Overall Survival and Mortality in Geriatric Turkish Patients with Multiple Myeloma
by: Yildiz Ipek, et al.
Published: (2023-06-01)

Modern strategies in therapy of elderly patients with multiple myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial
by: Ilaria Saltarella, et al.
Published: (2019-01-01)

Future Directions in Maintenance Therapy in Multiple Myeloma
by: Sarah A. Holstein, et al.
Published: (2021-05-01)

Efficiency and Tolerability of Induction and Consolidation Therapy with Arsenic Trioxide/Bortezomib/Ascorbic Acid/Dexamethasone (ABCD) Regimen Compared to Bortezomib/Dexamethasone (BD) Regimen in Newly Diagnosed Myeloma Patients
by: Qian W, et al.
Published: (2020-01-01)

Survival and Prognosis Analysis of Bortezomib Based Regimen in Newly Diagnosed Super-aged Multiple Myeloma Patients
by: ZHAO Fengyi, LI Xin, ZHAN Xiaokai, ZHANG Jiajia, SHEN Man, TANG Ran, FAN Sibin, HUANG Zhongxia
Published: (2024-03-01)

A Five-Gene Risk Score Model for Predicting the Prognosis of Multiple Myeloma Patients Based on Gene Expression Profiles
by: Xiaotong Chen, et al.
Published: (2021-11-01)

Natural History and Prognostic Factors at First Relapse in Multiple Myeloma
by: Chen Wang, et al.
Published: (2020-07-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

Bortezomib (velcade) plus melphalan and prednisone in elderly untreated patients with multiple myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Impact of ixazomib‐lenalidomide‐dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging‐markets subgroup of the TOURMALINE‐MM1 trial
by: Andrew Spencer, et al.
Published: (2022-11-01)

Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple Myeloma
by: Stephen Palmer, et al.
Published: (2023-06-01)

Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study
by: Marlies Antlanger, et al.
Published: (2018-10-01)

Socioeconomic Factors and Survival of Multiple Myeloma Patients
by: Kamal Chamoun, et al.
Published: (2021-02-01)

Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments
by: Luca Cancanelli, et al.
Published: (2023-01-01)

Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 Patients
by: Nikolaos Kanellias, et al.
Published: (2022-05-01)

Prognostic significance of dysregulation of shelterin complex and its correlation with telomere length and cytogenetics in multiple myeloma
by: Akanksha A. Kalal, et al.
Published: (2023-05-01)

Survival analysis of 6 737 surgically resected gastric cancer cases in China from a large single institution hospital-based cancer registry database
by: SHEN Jie, WANG Jiangli, WANG Zezhou, MO Miao, ZHOU Changming, YUAN Jing, XU Dazhi, ZHENG Ying
Published: (2024-03-01)

Overall survival of individuals with metastatic cancer in Sweden: a nationwide study
by: Greta Bütepage, et al.
Published: (2022-10-01)

Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial
by: Hans E. Johnsen, et al.
Published: (2009-08-01)

Frequency and prognostic significance of hypercalcemia in patients with multiple myeloma
by: Kanar J Karim, et al.
Published: (2020-01-01)

Super-Enhancer Associated Five-Gene Risk Score Model Predicts Overall Survival in Multiple Myeloma Patients
by: Tingting Qi, et al.
Published: (2020-12-01)

Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma
by: Cédric Gillich, et al.
Published: (2023-05-01)

The importance of serum immunoglobulin free light chain assessment for predicting outcome in patients with newly diagnosed multiple myeloma in real clinical practice
by: N. V. Skvortsova, et al.
Published: (2020-10-01)

Multiple Myeloma and Kidney Impairment at Diagnosis: A Nephrological Perspective from an Eastern European Country
by: Gabriel Ștefan, et al.
Published: (2023-07-01)

The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors
by: Barry Paul, et al.
Published: (2020-08-01)

Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis
by: Jon-Magnus Tangen, et al.
Published: (2018-08-01)

Prognostic value of the modified multiple myeloma comorbidity index in real clinical practice
by: N. V. Skvortsova, et al.
Published: (2020-10-01)